Medtronic plc (0Y6X.L)
USD 83.71
(1.22%)
USD 83.71
(1.22%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 16.12 Billion USD | 20.43% |
| 2022 | 13.39 Billion USD | -2.5% |
| 2021 | 13.73 Billion USD | 9.02% |
| 2020 | 12.6 Billion USD | -3.15% |
| 2019 | 13.01 Billion USD | 3.01% |
| 2018 | 12.63 Billion USD | 1.39% |
| 2017 | 12.45 Billion USD | 4.65% |
| 2016 | 11.9 Billion USD | 1.25% |
| 2015 | 11.75 Billion USD | 8.62% |
| 2014 | 10.82 Billion USD | 22.04% |
| 2013 | 8.86 Billion USD | 9.87% |
| 2012 | 8.07 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.88 Billion USD | 5.86% |
| 2023 Q1 | 3.33 Billion USD | -3.5% |
| 2023 Q2 | 3.28 Billion USD | -1.44% |
| 2023 Q3 | 3.43 Billion USD | 4.41% |
| 2023 Q4 | 3.67 Billion USD | 6.9% |
| 2023 FY | 13.72 Billion USD | 2.45% |
| 2022 Q3 | 3.35 Billion USD | 2.29% |
| 2022 Q4 | 3.45 Billion USD | 3.13% |
| 2022 Q1 | 3.38 Billion USD | 0.06% |
| 2022 Q2 | 3.27 Billion USD | -3.05% |
| 2022 FY | 13.39 Billion USD | -2.5% |
| 2021 Q1 | 4 Billion USD | 22.94% |
| 2021 FY | 13.73 Billion USD | 9.02% |
| 2021 Q2 | 3.29 Billion USD | -17.86% |
| 2021 Q3 | 3.11 Billion USD | -5.41% |
| 2021 Q4 | 3.37 Billion USD | 8.48% |
| 2020 Q2 | 3.97 Billion USD | 19.63% |
| 2020 FY | 12.6 Billion USD | -3.15% |
| 2020 Q1 | 3.32 Billion USD | -4.04% |
| 2020 Q3 | 3.82 Billion USD | -3.82% |
| 2020 Q4 | 3.26 Billion USD | -14.82% |
| 2019 Q2 | 3.96 Billion USD | 10.79% |
| 2019 FY | 13.01 Billion USD | 3.01% |
| 2019 Q4 | 3.46 Billion USD | -6.58% |
| 2019 Q3 | 3.71 Billion USD | -6.36% |
| 2019 Q1 | 3.57 Billion USD | -13.48% |
| 2018 Q2 | 3.7 Billion USD | -1.83% |
| 2018 Q4 | 4.13 Billion USD | 10.39% |
| 2018 Q3 | 3.74 Billion USD | 1.08% |
| 2018 Q1 | 3.77 Billion USD | -11.37% |
| 2018 FY | 12.63 Billion USD | 1.39% |
| 2017 Q1 | 3.56 Billion USD | -5.69% |
| 2017 FY | 12.45 Billion USD | 4.65% |
| 2017 Q3 | 3.89 Billion USD | 31.9% |
| 2017 Q4 | 4.25 Billion USD | 9.41% |
| 2017 Q2 | 2.95 Billion USD | -17.18% |
| 2016 Q1 | 3.74 Billion USD | 1.32% |
| 2016 FY | 11.9 Billion USD | 1.25% |
| 2016 Q4 | 3.77 Billion USD | -2.35% |
| 2016 Q3 | 3.86 Billion USD | 5.34% |
| 2016 Q2 | 3.67 Billion USD | -2.03% |
| 2015 Q3 | 3.43 Billion USD | -3.86% |
| 2015 FY | 11.75 Billion USD | 8.62% |
| 2015 Q1 | 3.91 Billion USD | -15.39% |
| 2015 Q2 | 3.57 Billion USD | -8.61% |
| 2015 Q4 | 3.69 Billion USD | 7.59% |
| 2014 Q2 | 2.19 Billion USD | 5.48% |
| 2014 FY | 10.82 Billion USD | 22.04% |
| 2014 Q4 | 4.62 Billion USD | 141.51% |
| 2014 Q3 | 1.91 Billion USD | -12.72% |
| 2014 Q1 | 2.08 Billion USD | -28.6% |
| 2013 Q4 | 2.91 Billion USD | 36.57% |
| 2013 Q2 | 1.95 Billion USD | 4.66% |
| 2013 Q1 | 1.86 Billion USD | -12.46% |
| 2013 Q3 | 2.13 Billion USD | 9.1% |
| 2013 FY | 8.86 Billion USD | 9.87% |
| 2012 Q4 | 2.13 Billion USD | 16.8% |
| 2012 FY | 8.07 Billion USD | 0.0% |
| 2012 Q3 | 1.82 Billion USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -4261.063% |
| Accuray Incorporated | 142.61 Million USD | -11209.311% |
| Align Technology, Inc. | 2.07 Billion USD | -676.618% |
| Elevance Health Inc. | 36.23 Billion USD | 55.489% |
| AxoGen, Inc. | 149.33 Million USD | -10700.477% |
| Boston Scientific Corporation | 7.5 Billion USD | -114.881% |
| CVS Health Corporation | 40.68 Billion USD | 60.359% |
| Cardinal Health, Inc. | 5 Billion USD | -222.58% |
| Centene Corporation | 138.33 Billion USD | 88.341% |
| DaVita Inc. | 1.47 Billion USD | -994.245% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 64.504% |
| Hologic, Inc. | 1.26 Billion USD | -1172.405% |
| Humana Inc. | 102.36 Billion USD | 84.243% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -1375.877% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -697.912% |
| Masimo Corporation | 867 Million USD | -1760.323% |
| McKesson Corporation | 8.67 Billion USD | -85.925% |
| Patterson Companies, Inc. | 1.12 Billion USD | -1330.741% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -901.801% |
| ResMed Inc. | 1.36 Billion USD | -1078.699% |
| Henry Schein, Inc. | 2.93 Billion USD | -449.166% |
| Teladoc Health, Inc. | 2.09 Billion USD | -671.377% |
| Universal Health Services, Inc. | 9.2 Billion USD | -75.156% |
| Veeva Systems Inc. | 1.25 Billion USD | -1183.085% |
| Baxter International Inc. | 5.27 Billion USD | -205.937% |
| Becton, Dickinson and Company | 6.71 Billion USD | -140.301% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | -444.402% |
| Danaher Corporation | 8.75 Billion USD | -84.226% |
| Stryker Corporation | 9.2 Billion USD | -75.144% |